Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, 57914 [2022-20528]

Download as PDF 57914 Federal Register / Vol. 87, No. 183 / Thursday, September 22, 2022 / Notices HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2022–20572 Filed 9–21–22; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Meeting of the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment Health Resources and Services Administration (HRSA), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: In accordance with the Federal Advisory Committee Act, this notice announces that the Secretary’s Centers for Disease Control and Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC) has scheduled a public meeting. Information about CHAC and the agenda for this meeting can be found on the CHAC website at https://www.cdc.gov/ maso/facm/facmCHACHSPT.html and the meeting website at https:// targethiv.org/ta-org/chac. DATES: • November 1, 2022, 12:30 p.m.–5:00 p.m. Eastern Time (ET); • November 2, 2022, 12:30 p.m.–5:30 p.m. ET; and • November 3, 2022, 12:30 p.m.–4:00 p.m. ET. ADDRESSES: This meeting will be held virtually. Advance registration is required to attend. Please visit the meeting website to register. The registration deadline is Friday, October 28, 2022, at 12:00 p.m. ET. Prior to the meeting, each individual registrant will receive a registration confirmation along with an access link to the virtual meeting location. • Meeting website link: https:// targethiv.org/ta-org/chac. FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Senior Public Health jspears on DSK121TN23PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:32 Sep 21, 2022 Jkt 256001 Advisor, HIV/AIDS Bureau, HRSA, 301– 443–5807; or CHACAdvisoryComm@ hrsa.gov. CHAC provides advice and recommendations to the Secretary of HHS (Secretary) on policy, program development, and other matters of significance concerning the activities under Section 222 of the Public Health Service Act, 42 U.S.C. 217a. The purpose of the CHAC is to advise the Secretary of HHS, the Director of CDC, and the HRSA Administrator regarding objectives, strategies, policies, and priorities for the prevention and treatment of HIV, viral hepatitis, and other STDs, including: surveillance, epidemiologic, behavioral, health services, and laboratory research, identification of policy issues related to professional eduction, patient healthcare delivery, and prevention services; Agency policies regarding health care delivery, research and training; strategic issues influencing the ability of CDC and HRSA to fulfill their missions programmatic efforts to prevent and treat HIV, viral hepatitis, and other STDs; and support to the CDC and HRSA in their development of responses to emerging health needs related to these issues. During the November 1–3, 2022, meeting, CHAC will discuss issues related to HIV and the workforce, including non-traditional partnerships to address people with HIV who are out of care, AIDS Education and Training Center program and integrating innovative programs to address HIV workforce challenges into the Ryan White HIV/AIDS Program, and how to more effectively use community health workers and disease intervention specialists in HIV and STD prevention, care, and treatment, along with a federal update on Monkeypox. Agenda items are subject to change as priorities dictate. Refer to the CHAC meeting information page for any updated information concerning the meeting. Members of the public will have the opportunity to provide comments. Public participants may also submit written statements as further described below. Oral comments will be honored in the order they are requested and may be limited as time allows. Requests to submit a written statement or make oral comments to CHAC should be sent via the meeting website at https:// targethiv.org/ta-org/chac. Requests for oral comment must be received by October 25, 2022, at 5 p.m. ET to be considered. Written comments may be submitted to Theresa Jumento at the email address and/or phone number SUPPLEMENTARY INFORMATION: PO 00000 Frm 00051 Fmt 4703 Sfmt 4703 listed above prior to and up to ten business days after the meeting. Visit the meeting information page for additional details: https://targethiv.org/ ta-org/chac. Individuals who plan to attend and need special assistance or another reasonable accommodation should notify Theresa Jumento at the email address and/or phone number listed above at least 10 business days prior to the meeting. Maria G. Button, Director, Executive Secretariat. [FR Doc. 2022–20528 Filed 9–21–22; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [Document Identifier: OS–4040–0004] Agency Information Collection Request. 30-Day Public Comment Request Office of the Secretary, HHS. Notice. AGENCY: ACTION: In compliance with the requirement of the Paperwork Reduction Act of 1995, the Office of the Secretary (OS), Department of Health and Human Services, is publishing the following summary of a proposed collection for public comment. DATES: Comments on the ICR must be received on or before October 24, 2022 ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: Sagal Musa, sagal.musa@hhs.gov or (202) 205–2634. When submitting comments or requesting information, please include the document identifier 4040–0004–30D and project title for reference. SUMMARY: Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects: (1) The necessity and utility of the proposed information collection for the proper performance of the agency’s functions; (2) the accuracy of the estimated burden; (3) ways to enhance the quality, utility, and clarity of the information to be collected; and SUPPLEMENTARY INFORMATION: E:\FR\FM\22SEN1.SGM 22SEN1

Agencies

[Federal Register Volume 87, Number 183 (Thursday, September 22, 2022)]
[Notices]
[Page 57914]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-20528]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Meeting of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, this 
notice announces that the Secretary's Centers for Disease Control and 
Prevention (CDC)/HRSA Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment (CHAC) has scheduled a public meeting. 
Information about CHAC and the agenda for this meeting can be found on 
the CHAC website at https://www.cdc.gov/maso/facm/facmCHACHSPT.html and 
the meeting website at https://targethiv.org/ta-org/chac.

DATES: 
     November 1, 2022, 12:30 p.m.-5:00 p.m. Eastern Time (ET);
     November 2, 2022, 12:30 p.m.-5:30 p.m. ET; and
     November 3, 2022, 12:30 p.m.-4:00 p.m. ET.

ADDRESSES: This meeting will be held virtually. Advance registration is 
required to attend. Please visit the meeting website to register. The 
registration deadline is Friday, October 28, 2022, at 12:00 p.m. ET. 
Prior to the meeting, each individual registrant will receive a 
registration confirmation along with an access link to the virtual 
meeting location.
     Meeting website link: https://targethiv.org/ta-org/chac.

FOR FURTHER INFORMATION CONTACT: Theresa Jumento, Senior Public Health 
Advisor, HIV/AIDS Bureau, HRSA, 301-443-5807; or 
[email protected].

SUPPLEMENTARY INFORMATION: CHAC provides advice and recommendations to 
the Secretary of HHS (Secretary) on policy, program development, and 
other matters of significance concerning the activities under Section 
222 of the Public Health Service Act, 42 U.S.C. 217a.
    The purpose of the CHAC is to advise the Secretary of HHS, the 
Director of CDC, and the HRSA Administrator regarding objectives, 
strategies, policies, and priorities for the prevention and treatment 
of HIV, viral hepatitis, and other STDs, including: surveillance, 
epidemiologic, behavioral, health services, and laboratory research, 
identification of policy issues related to professional eduction, 
patient healthcare delivery, and prevention services; Agency policies 
regarding health care delivery, research and training; strategic issues 
influencing the ability of CDC and HRSA to fulfill their missions 
programmatic efforts to prevent and treat HIV, viral hepatitis, and 
other STDs; and support to the CDC and HRSA in their development of 
responses to emerging health needs related to these issues.
    During the November 1-3, 2022, meeting, CHAC will discuss issues 
related to HIV and the workforce, including non-traditional 
partnerships to address people with HIV who are out of care, AIDS 
Education and Training Center program and integrating innovative 
programs to address HIV workforce challenges into the Ryan White HIV/
AIDS Program, and how to more effectively use community health workers 
and disease intervention specialists in HIV and STD prevention, care, 
and treatment, along with a federal update on Monkeypox. Agenda items 
are subject to change as priorities dictate. Refer to the CHAC meeting 
information page for any updated information concerning the meeting.
    Members of the public will have the opportunity to provide 
comments. Public participants may also submit written statements as 
further described below. Oral comments will be honored in the order 
they are requested and may be limited as time allows. Requests to 
submit a written statement or make oral comments to CHAC should be sent 
via the meeting website at https://targethiv.org/ta-org/chac. Requests 
for oral comment must be received by October 25, 2022, at 5 p.m. ET to 
be considered. Written comments may be submitted to Theresa Jumento at 
the email address and/or phone number listed above prior to and up to 
ten business days after the meeting. Visit the meeting information page 
for additional details: https://targethiv.org/ta-org/chac.
    Individuals who plan to attend and need special assistance or 
another reasonable accommodation should notify Theresa Jumento at the 
email address and/or phone number listed above at least 10 business 
days prior to the meeting.

Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2022-20528 Filed 9-21-22; 8:45 am]
BILLING CODE 4165-15-P